血清LYVE1与类风湿性关节炎的相关性分析
Correlation Analysis between Serum LYVE1 and Rheumatoid Arthritis
DOI: 10.12677/ACM.2024.142343, PDF,    国家自然科学基金支持
作者: 李骁瀚, 王洪星, 张 义*:山东大学齐鲁医院检验科,山东 济南;张小钰:中国人民解放军联勤保障部队第九六〇医院检验科,山东 济南
关键词: 类风湿性关节炎LYVE1血清标志物Rheumatoid Arthritis LYVE1 Serum Biomarkers
摘要: 目的:探究血清中淋巴管内皮透明质酸受体-1 (LYVE1)与类风湿性关节炎(RA)红细胞沉降率(ESR)以及RA相关血清标志物的相关性。方法:收集类风湿性关节炎、骨关节炎(OA)与健康体检者全血各10例,分别检测全血标本的红细胞沉降率以及血清中类风湿因子(RF)、抗循环瓜氨酸肽(Anti-CCP)抗体、C-反应蛋白(CRP)、LYVE1含量。通过泊松分布(Poisson distribution)模型分析血清中的LYVE1与其余血清学指标的相关性。结果:RA患者血清中LYVE1含量明显低于OA患者与健康体检者,差异具有统计学意义(p < 0.05)。RA患者血清中的LYVE1与ESR、RF、Anti-CCP抗体、CRP呈负相关。结论:LYVE1或许可以作为一种全新的血清标志物用于临床诊断RA与评估RA的进展。
Abstract: Objective: To explore the correlation between serum lymphatic endothelial hyaluronic acid recep-tor-1 (LYVE1) and rheumatoid arthritis (RA) erythrocyte sedimentation rate (ESR) and RA-related serum markers. Methods: Whole blood samples were collected from 10 cases, each of rheumatoid arthritis, osteoarthritis (OA), and healthy subjects. The ESR was measured for each sample. Subse-quently, serum was collected and the levels of rheumatoid factor (RF), anti-circulating citrullinated peptide (Anti-CCP) antibodies, C-reactive protein (CRP), and LYVE1 were measured. The correlation between LYVE1 in serum and other serological indicators was analyzed through the Poisson distri-bution model. Results: The serum LYVE1 content of RA patients was significantly lower than that of OA patients and healthy subjects, and the difference was statistically significant (p < 0.05). LYVE1 in the serum of RA patients was negatively correlated with ESR, RF, Anti-CCP antibodies and CRP. Con-clusion: LYVE1 may serve as a novel serum biomarker for clinical diagnosis and evaluation of RA progression.
文章引用:李骁瀚, 张小钰, 王洪星, 张义. 血清LYVE1与类风湿性关节炎的相关性分析[J]. 临床医学进展, 2024, 14(2): 2446-2452. https://doi.org/10.12677/ACM.2024.142343

参考文献

[1] Radu, A.F. and Bungau, S.G. (2021) Management of Rheumatoid Arthritis: An Overview. Cells, 10, Article No. 2857. [Google Scholar] [CrossRef] [PubMed]
[2] Scherer, H.U., Haupl, T. and Burmester, G.R. (2020) The Etiology of Rheumatoid Arthritis. Journal of Autoimmunity, 110, Article ID: 102400. [Google Scholar] [CrossRef] [PubMed]
[3] Akiyama, M. and Kaneko, Y. (2022) Pathogenesis, Clinical Fea-tures, and Treatment Strategy for Rheumatoid Arthritis-Associated Interstitial Lung Disease. Autoimmunity Reviews, 21, Article ID: 103056. [Google Scholar] [CrossRef] [PubMed]
[4] Figus, F.A., Piga, M., Azzolin, I., McConnell, R. and Iagnocco, A. (2021) Rheumatoid Arthritis: Extra-Articular Manifestations and Comorbidities. Autoimmunity Reviews, 20, Article ID: 102776. [Google Scholar] [CrossRef] [PubMed]
[5] Fedrigo, A., dos Santos, T.A.F.G., Nisihara, R. and Skare, T. (2018) The Lupus Patient with Positive Rheumatoid Factor. Lupus, 27, 1368-1373. [Google Scholar] [CrossRef] [PubMed]
[6] Skare, T.L., Nisihara, R., Barbosa, B.B., da Luz, A.R., Utiyama, S. and Picceli, V. (2013) Anti-CCP in Systemic Lupus Erythematosus Patients: A Cross Sectional Study in Brazilian Pa-tients. Clinical Rheumatology, 32, 1065-1070. [Google Scholar] [CrossRef] [PubMed]
[7] Singhal, S., et al. (2021) Bioavailable Turmeric Extract for Knee Osteoarthritis: A Randomized, Non-Inferiority Trial Versus Paracetamol. Trials, 22, Article No. 105. [Google Scholar] [CrossRef] [PubMed]
[8] Vadell, A.K.E., et al. (2020) Anti-Inflammatory Diet in Rheu-matoid Arthritis (ADIRA)—A Randomized, Controlled Crossover Trial Indicating Effects on Disease Activity. The American Journal of Clinical Nutrition, 111, 1203-1213. [Google Scholar] [CrossRef] [PubMed]
[9] Bray, C., et al. (2016) Erythrocyte Sedimentation Rate and C-Reactive Protein Measurements and Their Relevance in Clinical Medicine. WMJ, 115, 317-321.
[10] Chakarov, S., et al. (2019) Two Distinct Interstitial Macrophage Populations Coexist across Tissues in Specific Subtissular Niches. Science, 363, eaau0964. [Google Scholar] [CrossRef] [PubMed]
[11] Alivernini, S., et al. (2020) Distinct Synovial Tissue Mac-rophage Subsets Regulate Inflammation and Remission in Rheumatoid Arthritis. Nature Medicine, 26, 1295-1306. [Google Scholar] [CrossRef] [PubMed]
[12] Wada, I., et al. (2021) Retinal VEGF-A Overexpression Is Not Sufficient to Induce Lymphangiogenesis Regardless of VEGF-C Upregulation and Lyve1+ Macrophage Infiltration. In-vestigative Ophthalmology & Visual Science, 62, 17. [Google Scholar] [CrossRef] [PubMed]
[13] Nishida-Fukuda, H., et al. (2016) Ectodomain Shedding of Lymphatic Vessel Endothelial Hyaluronan Receptor 1 (LYVE-1) Is Induced by Vascular Endothelial Growth Factor A (VEGF-A). Journal of Biological Chemistry, 291, 10490-10500. [Google Scholar] [CrossRef
[14] Escal, J., Neel, T., Hodin, S., Boussoualim, K., et al. (2023) Proteomics Analyses of Human Plasma Reveal Triosephosphate Isomerase as a Potential Blood Marker of Methotrexate Resistance in Rheumatoid Arthritis. Rheumatology (Oxford), kead390. [Google Scholar] [CrossRef] [PubMed]
[15] Watanabe, R., Hashimoto, M., Murata, K., Murakami, K., et al. (2022) Prevalence and Predictive Factors of Difficult-to-Treat Rheumatoid Arthritis: The KURAMA Cohort. Immuno-logical Medicine, 45, 35-44. [Google Scholar] [CrossRef] [PubMed]
[16] Tiwari, V., Jandu, J.S. and Bergman, M.J. (2023) Rheuma-toid Factor. StatPearls, Treasure Island.
[17] Lisse, J.R. (1993) Does Rheumatoid Factor Always Mean Arthritis? Post-graduate Medicine, 94, 133-134, 139. [Google Scholar] [CrossRef] [PubMed]
[18] Ronnelid, J., Turesson, C. and Kastbom, A. (2021) Auto-antibodies in Rheumatoid Arthritis—Laboratory and Clinical Perspectives. Frontiers in Immunology, 12, Article ID: 685312. [Google Scholar] [CrossRef] [PubMed]
[19] Niewold, T.B., Harrison, M.J. and Paget, S.A. (2007) Anti-CCP Antibody Testing as a Diagnostic and Prognostic Tool in Rheumatoid Arthritis. QJM, 100, 193-201. [Google Scholar] [CrossRef] [PubMed]
[20] Pathak, A. and Agrawal, A. (2019) Evolution of C-Reactive Protein. Frontiers in Immunology, 10, Article No. 943. [Google Scholar] [CrossRef] [PubMed]
[21] Pope, J.E. and Choy, E.H. (2021) C-Reactive Protein and Implica-tions in Rheumatoid Arthritis and Associated Comorbidities. Seminars in Arthritis and Rheumatism, 51, 219-229. [Google Scholar] [CrossRef] [PubMed]
[22] Abramoff, B. and Caldera, F.E. (2020) Osteoarthritis: Pa-thology, Diagnosis, and Treatment Options. Medical Clinics of North America, 104, 293-311. [Google Scholar] [CrossRef] [PubMed]
[23] Ouyang, Z., Dong, L., Yao, F., et al. (2023) Cartilage-Related Collagens in Osteoarthritis and Rheumatoid Arthritis: From Pathogenesis to Therapeutics. International Journal of Mo-lecular Sciences, 24, Article No. 9841. [Google Scholar] [CrossRef] [PubMed]
[24] Mehta, B., Goodman, S., Di Carlo, E., et al. (2023) Machine Learning Identification of Thresholds to Discriminate Osteoarthritis and Rheumatoid Arthritis Synovial Inflammation. Arthritis Research & Therapy, 25, Article No. 31. [Google Scholar] [CrossRef] [PubMed]
[25] Kadomoto, S., Izumi, K. and Mizokami, A. (2021) Macrophage Polarity and Disease Control. International Journal of Molecular Sciences, 23, Article No. 144. [Google Scholar] [CrossRef] [PubMed]
[26] Yao, Y., et al. (2021) The Macrophage-Osteoclast Axis in Osteoim-munity and Osteo-Related Diseases. Frontiers in Immunology, 12, Article ID: 664871. [Google Scholar] [CrossRef] [PubMed]
[27] Kurowska-Stolarska, M. and Alivernini, S. (2022) Synovial Tis-sue Macrophages in Joint Homeostasis, Rheumatoid Arthritis and Disease Remission. Nature Reviews Rheumatology, 18, 384-397. [Google Scholar] [CrossRef] [PubMed]
[28] Pan, Y., Landis, J.T., Moorad, R., Wu, D., Marron, J.S. and Dittmer, D.P. (2023) The Poisson Distribution Model Fits UMI-Based Single-Cell RNA-Sequencing Data. BMC Bioin-formatics, 24, Article No. 256. [Google Scholar] [CrossRef] [PubMed]